Cargando…
Consumption of decaffeinated coffee protects against the development of early non-alcoholic steatohepatitis: Role of intestinal barrier function
BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) is one of the most common liver diseases worldwide lacking universally accepted therapies. Studies suggest that coffee consumption is associated with a reduced risk of NAFLD; however, molecular mechanisms and ingredients involved remain to be ful...
Autores principales: | Brandt, Annette, Nier, Anika, Jin, Cheng Jun, Baumann, Anja, Jung, Finn, Ribas, Vicent, García-Ruiz, Carmen, Fernández-Checa, Jose C., Bergheim, Ina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6313826/ https://www.ncbi.nlm.nih.gov/pubmed/30605883 http://dx.doi.org/10.1016/j.redox.2018.101092 |
Ejemplares similares
-
Oral Supplementation of Sodium Butyrate Attenuates the Progression of Non-Alcoholic Steatohepatitis
por: Baumann, Anja, et al.
Publicado: (2020) -
Fortifying Butterfat with Soybean Oil Attenuates the Onset of Diet-Induced Non-Alcoholic Steatohepatitis and Glucose Intolerance
por: Sánchez, Victor, et al.
Publicado: (2021) -
Citrulline supplementation attenuates the development of non-alcoholic steatohepatitis in female mice through mechanisms involving intestinal arginase
por: Rajcic, Dragana, et al.
Publicado: (2021) -
Alterations of nitric oxide homeostasis as trigger of intestinal barrier dysfunction in non‐alcoholic fatty liver disease
por: Baumann, Anja, et al.
Publicado: (2022) -
Metformin attenuates the onset of non-alcoholic fatty liver disease and affects intestinal microbiota and barrier in small intestine
por: Brandt, Annette, et al.
Publicado: (2019)